[1]
R. N. da . Gama, T. A. C. de . Lima, I. . Dangoni Filho, and M. F. P. . Peres, “A framework for decision making of migraine treatment with anti- CGRP monoclonal antibodies: a guide for real-world practice and public policies”, Headache Med, vol. 11, no. 3, pp. 72–76, Sep. 2020.